It has been noted in general that toxic manifestations resulting from the administration of sulfathiazole have been less than those encountered with some of the other sulfonamide derivatives. However, nausea, vomiting, fever, rashes and erythema nodosum have been reported.
References in the literature to the effects of sulfathiazole on the production of granulocytes have been few.1 Rheinhold, Flippin, and Schwartz2 state in referring to the use of sulfathiazole that repeated blood counts and hemoglobin determinations made during the course of administration of the drug failed to show evidence of any unusual depression in the number of white or red blood cells or in the concentration of hemoglobin. Leser3 observed that Long and Bliss, while treating 271 patients for a variety of disorders with sulfathiazole, found that "leukopenia and granulocytopenia occurred but not a single case of acute agranulocytosis." He further states that to date no deaths from
Hoyne AL, Larimore GW. SULFATHIAZOLE AS A CAUSE OF DEATH: REPORT OF PATIENT WITH ACUTE AGRANULOCYTOSIS. JAMA. 1941;117(16):1353–1354. doi:10.1001/jama.1941.72820420003013b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: